5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer

被引:0
|
作者
Grande, C. [1 ]
Martinez, M. [1 ]
Villanueva, M. J. [1 ]
Huidobro, G. [1 ]
Casal, J. [1 ]
机构
[1] Hosp Meixoeiro, Vigo, Spain
关键词
D O I
10.1016/S0959-8049(11)71903-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S469 / S469
页数:1
相关论文
共 50 条
  • [1] Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer
    Cao, Weiguo
    Yang, Weiping
    Lou, Guying
    Jiang, Jinsong
    Geng, Mei
    Xi, Wenqi
    Li, Hao
    Ma, Tao
    Jin, Yening
    [J]. ANTI-CANCER DRUGS, 2009, 20 (04) : 287 - 293
  • [2] A phase II study of irinotecan, oxaliplatin, 5-fluorouracil, leucovorin (FOLFOXIRI) as a first-line chemotherapy in metastatic gastric cancer.
    Lee, J.
    Kang, W.
    Lee, S.
    Kwon, J.
    Kim, H.
    Lee, H.
    Lim, H.
    Park, J.
    Park, Y.
    Park, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 197S - 197S
  • [3] First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule
    Masi, G
    Allegrini, G
    Cupini, S
    Marcucci, L
    Cerri, E
    Brunetti, I
    Fontana, E
    Ricci, S
    Andreuccetti, M
    Falcone, A
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (12) : 1766 - 1772
  • [4] Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis
    Liang Xiao-bo
    Hou Sheng-huai
    Li Yao-ping
    Wang Li-chun
    Zhang Xin
    Yang Jun
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3314 - 3318
  • [5] Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
    Kalofonos, HP
    Aravantinos, G
    Kosmidis, P
    Papakostas, P
    Economopoulos, T
    Dimopoulos, M
    Skarlos, D
    Bamias, A
    Pectasides, D
    Chalkidou, S
    Karina, M
    Koutras, A
    Samantas, E
    Bacoyiannis, C
    Samelis, GF
    Basdanis, G
    Kalfarentzos, F
    Fountzilas, G
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (06) : 869 - 877
  • [6] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    B Neri
    P Pantaleo
    E Giommoni
    R Grifoni
    C Paoletti
    V Rotella
    D Pantalone
    A Taddei
    A Mercatelli
    P Tonelli
    [J]. British Journal of Cancer, 2007, 96 : 1043 - 1046
  • [7] Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study
    Neri, B.
    Pantaleo, P.
    Giommoni, E.
    Grifoni, R.
    Paoletti, C.
    Rotella, V.
    Pantalone, D.
    Taddei, A.
    Mercatelli, A.
    Tonelli, P.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1043 - 1046
  • [8] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    [J]. CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [9] A Phase II Study of 5-Fluorouracil/Leucovorin in Combination with Paclitaxel and Oxaliplatin as First-Line Treatment for Patients with Advanced Gastric Cancer
    Lin, Rong-Bo
    Fan, Nan-Feng
    Guo, Zeng-Qing
    Wang, Xiao-Jie
    Liu, Jie
    Chen, Ling
    [J]. JOURNAL OF CHEMOTHERAPY, 2008, 20 (06) : 744 - 748
  • [10] First-line treatment of advanced gastric cancer and hepatic dysfunction with oxaliplatin, 5-fluorouracil and cetuximab
    Andrés Jesús Muñoz Martín
    Virginia Martínez Marín
    Juan Luis Arranz Cózar
    Luis Cabezón Gutiérrez
    Ricardo González del Val Subirats
    Pilar García Alfonso
    [J]. Clinical and Translational Oncology, 2008, 10 : 182 - 184